Synopsys (SNPS) Stock Forecast, Price & News

Synopsys (NASDAQ:SNPS) Frequently Asked Questions

Is Synopsys a buy right now?

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Synopsys in the last year. There are currently 1 sell rating, 1 hold rating and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Synopsys stock.
View analyst ratings for Synopsys or view top-rated stocks.

When is Synopsys' next earnings date?

Synopsys is scheduled to release its next quarterly earnings announcement on Wednesday, May 18th 2022.
View our earnings forecast for Synopsys.

How can I listen to Synopsys' earnings call?

Synopsys will be holding an earnings conference call on Wednesday, May 18th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 402-970-0847 with passcode "8770568".

How were Synopsys' earnings last quarter?

Synopsys, Inc. (NASDAQ:SNPS) released its quarterly earnings data on Wednesday, February, 16th. The semiconductor company reported $1.78 earnings per share for the quarter, missing analysts' consensus estimates of $1.79 by $0.01. The semiconductor company earned $1.27 billion during the quarter, compared to the consensus estimate of $1.27 billion. Synopsys had a trailing twelve-month return on equity of 16.74% and a net margin of 20.18%. The company's revenue was up 30.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.03 earnings per share.
View Synopsys' earnings history.

How will Synopsys' stock buyback program work?

Synopsys declared that its board has initiated a stock buyback program on Friday, December 10th 2021, which permits the company to repurchase $1,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to repurchase up to 1.8% of its stock through open market purchases. Stock repurchase programs are often an indication that the company's board believes its shares are undervalued.

What guidance has Synopsys issued on next quarter's earnings?

Synopsys issued an update on its FY 2022 earnings guidance on Wednesday, March, 9th. The company provided earnings per share (EPS) guidance of $7.850-$7.920 for the period, compared to the consensus earnings per share estimate of $7.810. The company issued revenue guidance of $4.78 billion-$4.83 billion, compared to the consensus revenue estimate of $4.76 billion.

What price target have analysts set for SNPS?

10 equities research analysts have issued 12 month price objectives for Synopsys' shares. Their forecasts range from $340.00 to $445.00. On average, they anticipate Synopsys' stock price to reach $385.78 in the next year. This suggests a possible upside of 40.9% from the stock's current price.
View analysts' price targets for Synopsys or view top-rated stocks among Wall Street analysts.

Who are Synopsys' key executives?

Synopsys' management team includes the following people:

• Dr. Aart J. de Geus, Co-Founder, Chairman & Co-CEO (Age 68, Pay $2.97M)
• Dr. Chi-Foon Chan Ph.D., Co-Chief Exec. Officer (Age 73, Pay $2.98M)
• Mr. Sassine Ghazi, Pres & COO (Age 51, Pay $4.78M) (LinkedIn Profile)
• Mr. Trac Pham, Chief Financial Officer (Age 53, Pay $1.37M) (LinkedIn Profile)
• Mr. John F. Runkel Jr., Gen. Counsel & Corp. Sec. (Age 66, Pay $987.7k)
• Mr. Joseph W. Logan, Chief Revenue Officer and Head of Sales & Customer Success Group (Age 62, Pay $1.67M) (LinkedIn Profile)
• Mr. Sudhindra Kankanwadi, Sr. VP of Fin., Chief Accounting Officer & Corp. Controller (Age 51) (LinkedIn Profile)
• Mr. Sriram Sitaraman, Chief Information Officer
• Ms. Lisa L. Ewbank, VP of Investor Relations
• Erika Varga McEnroe, Deputy Gen. Counsel and Chief Ethics & Compliance Officer

What is Dr. Aart J. de Geus and Dr. Chi-Foon Chan's approval rating as Synopsys' CEO?

1,170 employees have rated Synopsys CEO Dr. Aart J. de Geus and Dr. Chi-Foon Chan on Glassdoor.com. Dr. Aart J. de Geus and Dr. Chi-Foon Chan has an approval rating of 95% among Synopsys' employees. This puts Dr. Aart J. de Geus and Dr. Chi-Foon Chan in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Synopsys' key competitors?

Some companies that are related to Synopsys include Adobe (ADBE), Salesforce (CRM), Intuit (INTU), Workday (WDAY), Autodesk (ADSK), Cadence Design Systems (CDNS), ANSYS (ANSS), Splunk (SPLK), SS&C Technologies (SSNC), Tyler Technologies (TYL), FactSet Research Systems (FDS), Citrix Systems (CTXS), Aspen Technology (AZPN), Fair Isaac (FICO) and Manhattan Associates (MANH).
View all of SNPS's competitors.

What other stocks do shareholders of Synopsys own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Synopsys investors own include NVIDIA (NVDA), PayPal (PYPL), Alibaba Group (BABA), Square (SQ), Salesforce (CRM), Advanced Micro Devices (AMD), Adobe (ADBE), Tesla (TSLA), Netflix (NFLX) and Micron Technology (MU).

What is Synopsys' stock symbol?

Synopsys trades on the NASDAQ under the ticker symbol "SNPS."

Who are Synopsys' major shareholders?

Synopsys' stock is owned by many different institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (11.33%), BlackRock Inc. (8.84%), State Street Corp (4.12%), JPMorgan Chase & Co. (3.04%), Invesco Ltd. (1.70%) and Massachusetts Financial Services Co. MA (1.33%). Company insiders that own Synopsys stock include Chi-Foon Chan, Chrysostomos L Nikias, Geus Aart De, Janice Chaffin, John F Runkel Jr, Joseph W Logan, Mercedes Johnson, Roy Vallee, Sassine Ghazi, Steven Walske, Sudhindra Kankanwadi and Trac Pham.
View institutional ownership trends for Synopsys.

Which institutional investors are selling Synopsys stock?

SNPS stock was sold by a variety of institutional investors in the last quarter, including Parnassus Investments LLC, California Public Employees Retirement System, Nordea Investment Management AB, Twin Tree Management LP, Mackenzie Financial Corp, Mirae Asset Global Investments Co. Ltd., First Trust Advisors LP, and State Street Corp. Company insiders that have sold Synopsys company stock in the last year include Chi-Foon Chan, Chrysostomos L Nikias, Geus Aart De, Janice Chaffin, John F Runkel Jr, Joseph W Logan, Mercedes Johnson, Roy Vallee, Sassine Ghazi, Sudhindra Kankanwadi, and Trac Pham.
View insider buying and selling activity for Synopsys or view top insider-selling stocks.

Which institutional investors are buying Synopsys stock?

SNPS stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Goldman Sachs Group Inc., Van ECK Associates Corp, Vanguard Group Inc., Invesco Ltd., Wellington Management Group LLP, Prudential Financial Inc., and Aaron Wealth Advisors LLC.
View insider buying and selling activity for Synopsys or or view top insider-buying stocks.

How do I buy shares of Synopsys?

Shares of SNPS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Synopsys' stock price today?

One share of SNPS stock can currently be purchased for approximately $273.73.

How much money does Synopsys make?

Synopsys has a market capitalization of $41.91 billion and generates $4.20 billion in revenue each year. The semiconductor company earns $757.52 million in net income (profit) each year or $5.779990 on an earnings per share basis.

How many employees does Synopsys have?

Synopsys employs 16,361 workers across the globe.

Does Synopsys have any subsidiaries?

The following companies are subsidiares of Synopsys: Accelerant Networks, Advanced Test Technology Inc., Analog Design Automation, Arcad SA, ArchPro Design Automation, Avant! Corp., Black Duck Software, Black Duck Software Inc., Cadis GmbH, Cascade Semiconductor Solutions, Chipidea Microelectrónica, Cigital, CiraNova, Co-Design Automation, CoWare, Codenomicon, Codiscope, Compiled Designs GmbH, Conversant Intellectual Property Management, Coverity, Coverity LLC, EPIC Design Technology, Elliptic Technologies, Emulation and Verification Engineering, Everest Design Automation, ExperTest, ExpertIO, Extreme DA, Forcheck, Gambit Automated Design, Gemini Design Technology, Goanna Software, Gold Standard Simulations, HPL Technologies Inc., InnoLogic Systems, Integrated Systems Engineering, Kilopass Technology, LEDA Systems, Leda SA, Logic Modeling Corporation, Magma Design Automation, MoSys Inc., Monterey Design Systems, Moortec Semiconductor, Nassda, Nihon Synopsys G.K., Numerical Technologies Inc., Nusym Technology, Optical Research Associates, PhoeniX Software, Pro Design Electronic - CHIPit, Progressant Technologies, Protecode, QTronic GmbH, QuantumWise, RSoft Design Group, Radiant Design Tools, SIGMA-C Software AG, SNPS Ireland New Limited, Sandwork Design Inc., Sidense, Silicon Architects, Simpleware, Smartech Oy, SpringSoft, Stanza Systems, Synfora, Synopsys (India) Private Limited, Synopsys Emulation and Verification S.A.S., Synopsys Global Kft., Synopsys International Limited, Synopsys International Old Unlimited Company, Synopsys International Services Inc., Synopsys Ireland New Limited, Synopsys Ireland Unlimited Company, Synopsys Korea Inc., Synopsys Netherlands B.V., Synopsys Taiwan Co. Ltd., Synopsys Technologies Company Limited, Synopsys Technologies Holding LLC, Synopsys USIE Holdings LLC, Synplicity Inc, Systems Science, Target Compiler Technologies, Terrain EDA, Tinfoil Security, TriCN Associates, VaST Systems Technology, Viewlogic Systems, Virage Logic Corporation, Virtio, WinterLogic, ZEROSOFT, inSilicon Corp., and nSys Design Systems.

When was Synopsys founded?

Synopsys was founded in 1986.

What is Synopsys' official website?

The official website for Synopsys is www.synopsys.com.

How can I contact Synopsys?

Synopsys' mailing address is 690 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA, 94043. The semiconductor company can be reached via phone at (650) 584-5000, via email at [email protected], or via fax at 650-965-8637.